The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, explanatory content, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

The INS Peer-Reviewed Journal – 8 Issues a Year

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online.

journal cover

+Submit a Manuscript.+

What is Neuromodulation?

Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

Breaking News Share

Unanticipated Response Noted in Cingulum Stimulation During Pre-Surgical Epilepsy Brain Mapping

March 21, 2019 - A clinician reports affective response in three epilepsy patients from brain stimulation to the dorsal anterior segment of the cingulum bundle, which was carried out during pre-surgical mapping. He purports the finding may have potential implications for surgery. (Neurology Today)

Chronic Pain Neurostimulator Available in Canada

March 21, 2019 - An article announces the availability of a wireless spinal cord stimulator in Canada for chronic pain. (Daily American)

Article Covers Several Bioelectronic Therapy Developments

March 20, 2019 - An article about electroceuticals summarizes developments at six neuromodulation companies that have developed devices for a range of conditions. (Nanalyze)

Article Summarizes Deep Brain Stimulation Findings in Several Conditions Other Than Movement Disorders

March 12, 2019 - Recent findings are summarized in brain-stimulation implants in epilepsy, treatment-resistant depression, and Alzheimer's disease. Deep brain stimulation history and neuronal and vascular effects are also discussed. (PNAS)

Device Maker Partners with a U.S. Insurance-Claims-Processing Medical Equipment Distributor

March 20, 2019 - Endonovo Therapeutics, Inc., which markets a noninvasive stimulator for treatment of soft tissue injury and chronic wounds, announced a partnership with a provider of Medicare and Medicaid claims service and equipment, SunMED Medical Solutions. (Nasdaq)

Review Summarizes Approaches to Transcranial Magnetic Stimulation Treatment in Trauma-Related Conditions

March 19, 2019 - A review looks at repetitive transcranial magentic stimulation in trauma-related conditions, and treatment frequencies and stimulation targets used in the presence of post-traumatic stress disorder. (Neuropsychiatric Disease and Treatment)

Company Seeks FDA Approval for Use of Its Noninvasive Brain Stimulation in Alzheimer's Disease

March 19, 2019 - An FDA advisory panel will be discussing an application for Neuronix's NeuroAD machine, which provides transcranial magnetic stimulation, to be approved for use in slowing development of Alzheimer's symptoms when used in conjunction with cognitive training. (IEEE Spectrum)

Researchers Examine Changes in Quality of Life for Parkinson's Disease Patients After Deep Brain Stimulation

March 19, 2019 - A study in Neurology examined the changes in quality of life of Parkinson's disease patients who participated in a deep brain stimulation study for patients younger than 61, finding a difference in improvement depending on the baseline level. (Parkinson's News Today)

Researchers In Germany Report on Deep Brain Stimulation in Major Depression

March 19, 2019 - An article in Neuropsychopharmacology reports on deep brain stimulation to part of the brain's reward system, the superoloateral medial forebrain bundle, in major depression. (EurekAlert)

To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs
Last Updated on Monday, December 12, 2016 10:01 AM